• HOME
  • ABOUT
  • CLASS ACTIONS
    • ParaGard IUD
  • MASS TORTS
    • PARAQUAT
    • Toxic Infant Formula
    • AFFF Firefighting Foam
    • Philips CPAP Machine
    • Camp Lejeune
  • DEFECTIVE PRODUCTS
    • HAIR STRAIGHTENER LAWSUIT
    • Neurovascular Stent Lawsuit
  • WHISTLEBLOWER
  • BLOG
  • RESOURCE CENTER
  • CONTACT
  • DISCLAIMER
    • PRIVACY NOTICE
  • HOME
  • ABOUT
  • CLASS ACTIONS
    • ParaGard IUD
  • MASS TORTS
    • PARAQUAT
    • Toxic Infant Formula
    • AFFF Firefighting Foam
    • Philips CPAP Machine
    • Camp Lejeune
  • DEFECTIVE PRODUCTS
    • HAIR STRAIGHTENER LAWSUIT
    • Neurovascular Stent Lawsuit
  • WHISTLEBLOWER
  • BLOG
  • RESOURCE CENTER
  • CONTACT
  • DISCLAIMER
    • PRIVACY NOTICE
Legal Guides for consumers

Categories

All
Camp Lejeune
Civil Prodedure
Class Actions
Dangerous Drugs
Defective Products
Hair Straightener
Mass Torts
Neurovascular Stent
Nursing Home Abuse
Securities Fraud
Social Media
Wage An Hour
Whistleblower

Four Frequently Asked Questions in the Singulair Mental Health Lawsuits

8/26/2022

 
Picture of pillsCall Singulair Lawyer Timothy L. Miles Today
Singulair (montelukast) is a drug prescribed to patients suffering from asthma or severe allergies that can provide symptom relief and help them manage their condition. It is a very successful drug for its manufacturer, Merck & Co. Singulair received the U.S. Food & Drug Administration’s (FDA) marketing approval in 1998; by 2004, Singulair was doing $2.62 billion in sales.
​
But by 2009, there were concerns that Singulair may have an adverse effect on its users’ mental health. That year, the FDA updated its potential side effect warning about Singulair to include the potential for “neuropsychiatric events.”

​The FDA warned that the potential adverse mental health symptoms could include: ”postmarket cases of agitation, aggression, anxiousness, dream abnormalities and hallucinations, depression, insomnia, irritability, restlessness, suicidal thinking and behavior (including suicide), and tremor.”

These concerns have only grown over time — in March 2020, the FDA began requiring a “black box” warning label (the FDA’s highest danger advisory) on every unit of Singulair, warning of the potential for severe mental health symptoms, including suicidal ideation and attempted suicide.

In light of these mounting concerns, the FDA now advises against the use of Singulair to treat seasonal or chronic allergies, except in cases where no other medication works for that specific patient. 

Merck & Co. is now facing Singulair mental health lawsuits from Singulair users who allege that the medication caused them to experience adverse mental health symptoms, including suicidal ideation. If you or a loved one have taken singulair and experienced suicidal ideation or other adverse Singulair mental health symptoms, you may be eligible for compensation. Contact a Singulair Lawyer today. Read on for answers to four frequently asked questions in the Singulair Mental Health Lawsuits.

How Were the Singulair Mental Health Symptoms Discovered?

​The FDA based their new warnings and recommendations on Singulair-associated neuropsychiatric incidents that were reported to the FDA’s Sentinel Initiative, as well as animal studies and reports of suicides.  The FDA identified 82 cases where a sucide was linked to montelukast. Forty-five cases involved a patient older than 17, 19 involved one younger than 17, and 18 case reports did not indicate the patient’s age.  A study of montelukast in mice found the drug molecule inside the brain, indicating that the drug can cross the blood-brain barrier. This would suggest that montelukast/Singulair could enter and harm the brain as well.  The combination of all this information caused the FDA to update their assessment of the possible mental health risks posed by taking Singulair.

What Are the Singulair Mental Health Symptoms

​A wide range of adverse Singulair mental health symptoms have reportedly been experienced by Singulair users. These include: Suicidal thoughts, potentially escalating to suicidal ideation and attempted suicide
  • Insomnia
  • Nightmares
  • Anxiety
  • Increased aggression
  • Restlessness
  • Irritability
  • Memory issues
  • Sleepwalking
  • Depression
  • Lack of focus and reduced ability to concentrate
  • Body tremors
If you or a loved one has experienced any of these Singulair mental health symptoms, you may have grounds for a Singulair lawsuit against the drug manufacturer.  Contact Singulair Lawyer Timothy L. Miles today.

Should I Stop Taking Singulair?

​You should talk to your doctor about your options before making any changes. The FDA has expressed concerns that not all doctors and healthcare providers are currently aware of the updated understanding of Singulair’s risk profile, so make sure that your doctor knows about the March 2020 FDA update. 

Am I Eligible for The Singulair Mental Health Lawsuits?

​If you or a loved one took Singulair and has since experienced any of the above adverse mental health symptoms, you may be eligible for a Singulair lawsuit. If successful, you could win compensation for any financial losses incurred due to your symptoms, including medical costs, as well as damages for pain and suffering. 

Call a Singulair Lawyer today about a Singulair Lawsuit

​If you or a loved one is suffering from adverse Singulair mental health symptoms, you may be eligible for compensation. A Singulair Lawyer is standing by ready to review your case for free, and if we take your case, you won’t pay anything up front; you won’t pay at all unless we win for you. Call Singulair Lawyer Timothy L. Miles at (855) Tim-M-Law or click here for a free case evaluation to discuss a Singulair Lawsuit.

Timothy L. Miles, Esq.

Timothy L. Miles is a nationally recognized shareholder rights attorney raised in Nashville, Tennessee. Mr. Miles was recentely selected by Martindale-Hubbell® and ALM as a 2022 Top Ranked Lawyer, 2022 Top Rated Litigator. and a 2022 Elite Lawyer of the South. Mr. Miles also maintains the AV Preeminent Rating by Martindale-Hubbell®, their highest rating for both legal ability and ethics. Mr. Miles is a member of the prestigious Top 100 Civil Plaintiff Trial Lawyers: The National Trial Lawyers Association, a superb rated attorney by Avvo, a recipient of the Lifetime Achievement Award by Premier Lawyers of America (2019) and recognized as a Distinguished Lawyer, Recognizing Excellence in Securities Law, by Lawyers of Distinction (2019). Mr. Miles has published over sixty articles on various issues of the law, including class actions, whistleblower cases, products liability, and more.


Comments are closed.

    Author

    Timothy L. Miles
    Class Actions | Mass Torts 

    Archives

    June 2023
    May 2023
    April 2023
    February 2023
    January 2023
    December 2022
    November 2022
    October 2022
    September 2022
    August 2022
    July 2022
    June 2022
    May 2022
    March 2022
    February 2022
    January 2022
    December 2021

    Categories

    All
    Camp Lejeune
    Civil Prodedure
    Class Actions
    Dangerous Drugs
    Defective Products
    Hair Straightener
    Mass Torts
    Neurovascular Stent
    Nursing Home Abuse
    Securities Fraud
    Social Media
    Wage An Hour
    Whistleblower

Hours of Operation


Mon - Fri:  24/7
Sat - Sun:  24/7


​​CONNECT

Facebook
Instagram
Twitter
Linkedin
YouTube
Pinterest
Tiktok

Contact Information

Phone: (855) Tim-M-Law (855-846-6529)
Email: [email protected]
​
​Website:

www.classactionlawyertn.com

​

Address:300 Centerview Dr., #247
Brentwood, TN 37027
(855) Tim-M-Law (855-846-6529))

​2022 © Timmileslaw.com | All Rights Reserved 
​Tim Miles Law Office | Class Actions | Mass Torts